FR2528837A1 - Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication - Google Patents
Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication Download PDFInfo
- Publication number
- FR2528837A1 FR2528837A1 FR8210630A FR8210630A FR2528837A1 FR 2528837 A1 FR2528837 A1 FR 2528837A1 FR 8210630 A FR8210630 A FR 8210630A FR 8210630 A FR8210630 A FR 8210630A FR 2528837 A1 FR2528837 A1 FR 2528837A1
- Authority
- FR
- France
- Prior art keywords
- pyridazinone
- och
- derivatives
- compounds
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8210630A FR2528837A1 (fr) | 1982-06-18 | 1982-06-18 | Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication |
CH320483A CH657125B (de) | 1982-06-18 | 1983-06-10 | |
NL8302087A NL8302087A (nl) | 1982-06-18 | 1983-06-11 | Pyridazinonverbindingen, werkwijze voor de bereiding hiervan en de toepassing als geneesmiddel. |
GR71641A GR78284B (de) | 1982-06-18 | 1983-06-13 | |
DE3321772A DE3321772A1 (de) | 1982-06-18 | 1983-06-16 | Pyridazinon-derivate, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel |
JP58108026A JPS5910571A (ja) | 1982-06-18 | 1983-06-17 | 医薬品として使用可能なピリダジノンの誘導体、及びそれの製造方法 |
KR1019830002710A KR860001339B1 (ko) | 1982-06-18 | 1983-06-17 | 피리다지논 유도체의 제조방법 |
IT8321684A IT1194281B (it) | 1982-06-18 | 1983-06-17 | Derivati di piridazinoni impiegabili come sostanze medicinali e procedimento per la loro fabricazione |
GB08316516A GB2122195A (en) | 1982-06-18 | 1983-06-17 | Pyridazinones |
BE0/211031A BE897085A (fr) | 1982-06-18 | 1983-06-17 | Derives de pyridazinones utilisables comme medicaments et procedes pour leur fabrication |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8210630A FR2528837A1 (fr) | 1982-06-18 | 1982-06-18 | Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2528837A1 true FR2528837A1 (fr) | 1983-12-23 |
FR2528837B1 FR2528837B1 (de) | 1984-12-07 |
Family
ID=9275129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8210630A Granted FR2528837A1 (fr) | 1982-06-18 | 1982-06-18 | Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS5910571A (de) |
KR (1) | KR860001339B1 (de) |
BE (1) | BE897085A (de) |
CH (1) | CH657125B (de) |
DE (1) | DE3321772A1 (de) |
FR (1) | FR2528837A1 (de) |
GB (1) | GB2122195A (de) |
GR (1) | GR78284B (de) |
IT (1) | IT1194281B (de) |
NL (1) | NL8302087A (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0129791A2 (de) * | 1983-06-20 | 1985-01-02 | CASSELLA Aktiengesellschaft | Tetrahydropyridazinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0210530A1 (de) * | 1985-07-27 | 1987-02-04 | MERCK PATENT GmbH | 6-Arylalkenylpyridazinone |
JPS63220512A (ja) * | 1987-03-09 | 1988-09-13 | 松下電器産業株式会社 | 電解コンデンサ用電極箔 |
JPH04100106U (de) * | 1991-02-12 | 1992-08-28 | ||
JPH0776050B2 (ja) * | 1991-07-25 | 1995-08-16 | 実 近藤 | ワークの移送装置 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2304977A1 (de) * | 1973-02-01 | 1974-08-08 | Basf Ag | Neue dihydropyridazinone |
-
1982
- 1982-06-18 FR FR8210630A patent/FR2528837A1/fr active Granted
-
1983
- 1983-06-10 CH CH320483A patent/CH657125B/fr unknown
- 1983-06-11 NL NL8302087A patent/NL8302087A/nl not_active Application Discontinuation
- 1983-06-13 GR GR71641A patent/GR78284B/el unknown
- 1983-06-16 DE DE3321772A patent/DE3321772A1/de not_active Withdrawn
- 1983-06-17 BE BE0/211031A patent/BE897085A/fr not_active IP Right Cessation
- 1983-06-17 KR KR1019830002710A patent/KR860001339B1/ko active IP Right Grant
- 1983-06-17 JP JP58108026A patent/JPS5910571A/ja active Pending
- 1983-06-17 IT IT8321684A patent/IT1194281B/it active
- 1983-06-17 GB GB08316516A patent/GB2122195A/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2304977A1 (de) * | 1973-02-01 | 1974-08-08 | Basf Ag | Neue dihydropyridazinone |
Non-Patent Citations (3)
Title |
---|
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, volume 49, no. 4, avril 1976 (TOKYO, JP) T. SATO et al. "A convenient synthesis of beta-acetyl-gamma-substituted-gamma-butyrolactones and gamma-acetyl-delta-substituted-delta-valerolactones", pages 1055-1058 * |
CHEMICAL ABSTRACTS, volume 72, no. 2, 12 janvier 1970, page 458, abrégé 9048r (COLUMBUS OHIO, US) & Suom. Kemistilehti B 1969, 42(7-8), 312-13, S. ESKOLA et al. "Thin-layer chromatographic study of some 3-methyl-6-pyridazinone derivatives" * |
CHEMICAL ABSTRACTS, volume 95, no. 23, 7 décembre 1981, page 50, abrégé 197388y (COLUMBUS OHIO, US) & Ann. Pharm. Fr. 1981, 39(3), 215-22, PHAM HUU CHANH et al. "Cardiostimulant action and hemodynamic effects of a new beta-acetyl butyrolactone" * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0129791A2 (de) * | 1983-06-20 | 1985-01-02 | CASSELLA Aktiengesellschaft | Tetrahydropyridazinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
EP0129791A3 (de) * | 1983-06-20 | 1987-06-10 | CASSELLA Aktiengesellschaft | Tetrahydropyridazinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
Also Published As
Publication number | Publication date |
---|---|
GB2122195A (en) | 1984-01-11 |
GB8316516D0 (en) | 1983-07-20 |
FR2528837B1 (de) | 1984-12-07 |
IT1194281B (it) | 1988-09-14 |
KR860001339B1 (ko) | 1986-09-15 |
BE897085A (fr) | 1983-12-19 |
JPS5910571A (ja) | 1984-01-20 |
DE3321772A1 (de) | 1983-12-22 |
KR840005105A (ko) | 1984-11-03 |
NL8302087A (nl) | 1984-01-16 |
GR78284B (de) | 1984-09-26 |
IT8321684A0 (it) | 1983-06-17 |
CH657125B (de) | 1986-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0318377B1 (de) | Enantiomere Derivate von Aminosäure, Verfahren zu deren Herstellung und deren therapeutische Verwendung | |
EP0352301A1 (de) | Buttersäure-ester und ihre verwendung als arzneimittel | |
EP0067086A1 (de) | Benzoxepinderivate und ihre Schwefel- und Stickstoffanaloge, Verfahren zu ihrer Herstellung und ihre Verwendung als Heilmittel | |
EP0138721B1 (de) | Benzensulfonyllactame, Verfahren zu ihrer Herstellung und ihre Anwendung als wirksame Bestandteile in pharmazeutischen Zusammensetzungen | |
FR2528837A1 (fr) | Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication | |
EP0366511A1 (de) | Benzoxazolinon-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten | |
EP0239436B1 (de) | Tricyclisches Derivat, nämlich 5-(3-Chloro-6-methyl-5,5-dioxo-6,11-dihydro-dibenzo[c,f] [1,2]-thiazepin-11-yl amino)-pentansäure, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel | |
FR2577552A1 (fr) | Esters heterocycliques dissymetriques d'acides 1,4-dihydropyridine-3,5-dicarboxyliques, procede de preparation et utilisation en therapeutique | |
CA2022732A1 (fr) | Derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
FR2570701A1 (fr) | Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique | |
EP0151140B1 (de) | Salz von 2-piperazinopyrimidin, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammenstellungen | |
CA2045849A1 (fr) | Derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
FR2514006A1 (fr) | Acylamino-4 aza-1 adamantanes, procede pour leur preparation, et application en therapeutique | |
EP0240398A1 (de) | Dissymmetrische 1,4-Dihydropyridin-3,5-dicarbonsäure-Derivate, Verfahren zur Herstellung und Verwendung in Therapeutik | |
EP0094283B1 (de) | Arzneimittelform von Theophyllin mit verlängerter Wirkung | |
WO1981002295A1 (fr) | Phenoxyisobutyrates de moroxydine et medicaments les contenant | |
FR2636065A1 (fr) | Nouveaux derives de dihydro-2,3 arylacoylaminoalcoyl-3 4h-benzoxazine-1,3 ones-4, leur preparation et leur application en tant que medicaments utiles en therapeutique | |
FR2526793A1 (fr) | Nouveaux a-(n-pyrrolyl)-acides et leurs sels et esters, utiles comme medicaments et procede de la preparation de tels composes | |
CA1125743A (fr) | Derives d'amino-3-cardenolides, procede pour leur preparation, et medicaments les contenant | |
FR2518537A1 (fr) | Nouveaux derives de l'acide phenylacetique, leur preparation et compositions les contenant | |
EP0412898A1 (de) | Oxazolopyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
FR2673105A1 (fr) | Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections. | |
CA1191837A (fr) | Procede de peparation de nouveaux agents carcinostatiques et medicaments ainsi obtenus | |
FR2708611A1 (fr) | Sel de codéine de l'acide 2-(3-benzoylphényl)propionique, procédé d'obtention et compositions pharmaceutiques le contenant. | |
CH618977A5 (de) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |